Is Blockholder Diversity Detrimental?
Management Science · 2025-02 · 71 (2) · 1356-1390
DOI: 10.1287/mnsc.2023.00528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Management Science, 2025-02. Verfasst von Miriam Schwartz-Ziv und 1 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
We find that, overall, blockholder diversity, i.e., the firm shareholder base including several different types of blocks, is detrimental to firm performance. We show that lagged disclosure, on exogenous predetermined dates, that reveals an increase in block diversity is followed by a negative market reaction. Firms held by heterogeneous blockholders consistently perform worse than firms held by homogeneous blockholders. Block diversity is particularly detrimental when uncertainty is high. Disagreement among shareholders (e.g., as reflected in the frequency of lawsuits being filed) increases when the blockholder base is diverse. We make our blockholder data set public for the benefit of other researchers. This paper was accepted by Victoria Ivashina, finance. Funding: This work was supported by the Israel Science Foundation [Grant 264/20], the Faculty of Business and Economics, University of Melbourne [Grant ECR00009FNL], and the Accounting and Finance Association of Australia and New Zealand [Grant 2020-033]. Supplemental Material: The online appendices and data files are available at https://doi.org/10.1287/mnsc.2023.00528 .
Zitieren
APA
Schwartz-Ziv, M., & Volkova, E. (2025). Is Blockholder Diversity Detrimental?. Management Science, 71(2), 1356-1390. https://doi.org/10.1287/mnsc.2023.00528
Vancouver
Schwartz-Ziv M, Volkova E. Is Blockholder Diversity Detrimental?. Management Science. 2025;71(2):1356-1390. doi:10.1287/mnsc.2023.00528
BibTeX
@article{SchwartzZiv2025,
author = {Schwartz-Ziv, Miriam and Volkova, Ekaterina},
title = {Is Blockholder Diversity Detrimental?},
journal = {Management Science},
year = {2025},
volume = {71},
number = {2},
pages = {1356--1390},
doi = {10.1287/mnsc.2023.00528}
}
EUVIMED